In an MLL-AF9–induced mouse AML model, Notch signaling was inactive in CD34+/CD38- stem/progenitor cells and upregulation of Notch signaling using genetic Notch gain of function models could result in the proliferation inhibition of this populations. This evidence concerns the gene CD38 and acute myeloid leukemia.